Author
Larry J. Copeland
Also Known As
&NA;, C A Young, L Copeland, L J Copeland, L Wyatt, L. Copeland, L. J. COPELAND, L. J. Copeland, L.J. COPELAND, L.J. Copeland
359
Publications
14.6K
Citations
57
H-Index
138
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 48 | 111 | 6.8K |
2 | Public Health | 16 | 18 | 819 |
3 | Health Sciences | 11 | 11 | 1K |
4 | Social Sciences | 2 | 2 | 273 |
5 | Nursing | 1 | 1 | 59 |
Larry J. Copeland
×
145
Publications
13.4K
Citations
55
H-Index
| Year | Citations | |
|---|---|---|
2006 | 2.6K | |
2023 | 718 | |
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240) Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson, Advanced Cervical CancerCervical Cancer ManagementCervical CancerCervical HealthMedicine | 2017 | 656 |
2006 | 629 | |
2019 | 461 | |
2003 | 457 | |
2016 | 318 | |
2006 | 253 | |
2012 | 196 | |
1999 | 176 |
Page 1
Page 1